Acidic phospholipids, unsaturated fatty acids and limited proteolysis mimic the activating effect of calmodulin on erythrocyte Ca2+-transport ATPase and on brain cyclic nucleotide phosphodiesterase, as has been reported previously in several studies. Three different antagonists of calmodulin-induced activation of these enzymes were tested for their inhibitory potency on the stimulation produced by the other activators. Trifluoperazine and penfluridol were found to antagonize all the above mentioned types of activation of Ca2+-transport ATPase in the same concentration range. Both inhibitors also can reverse the activation of phosphodiesterase by oleic acid, phosphatidylserine and calmodulin at similar concentrations. However, in contrast with erythrocyte Ca2+-transport ATPase, activation of phosphodiesterase by limited tryptic digestion cannot be antagonized by penfluridol and trifluoperazine. Calmidazolium, formerly referred to as compound R 24571, was found to be a relatively specific inhibitor of calmodulin-induced activation of phosphodiesterase and Ca2+-transport ATPase, since antagonism of the other activators required much higher concentrations of the drug. The results suggest that the investigated drugs exert their inhibitory effect on calmodulin-regulated enzymes not solely via their binding to calmodulin but may also interfere directly with the calmodulin effector enzyme. In addition, a general mechanism of activation and inhibition of calmodulin-dependent enzymes is derived from our results.
Acidic phospholipids, unsaturated fatty acids and limited proteolysis mimic the activating effect of calmodulin on erythrocyte Ca2+-transport ATPase and on brain cyclic nucleotide phosphodiesterase, as has been reported previously in several studies. Three different antagonists of calmodulin-induced activation of these enzymes were tested for their inhibitory potency on the stimulation produced by the other activators. Trifluoperazine and penfluridol were found to antagonize all the above mentioned types of activation of Ca2+-transport ATPase in the same concentration range. Both inhibitors also can reverse the activation of phosphodiesterase by oleic acid, phosphatidylserine and calmodulin at similar concentrations. However, in contrast with erythrocyte Ca2+-transport ATPase, activation of phosphodiesterase by limited tryptic digestion cannot be antagonized by penfluridol and trifluoperazine. Calmidazolium, formerly referred to as compound R 24571, was found to be a relatively specific inhibitor of calmodulin-induced activation of phosphodiesterase and Ca2+-transport ATPase, since antagonism of the other activators required much higher concentrations of the drug. The results suggest that the investigated drugs exert their inhibitory effect on calmodulin-regulated enzymes not solely via their binding to calmodulin but may also interfere directly with the calmodulin effector enzyme. In addition, a general mechanism of activation and inhibition of calmodulin-dependent enzymes is derived from our results.
Calmodulin is a Ca2+-binding protein that modulates a number of Ca2+-dependent enzymes and cell functions, and is a major cytoplasmic receptor for Ca2+ (Cheung, 1980; Means & Dedman, 1980) . The calmodulin-dependent fraction of the activity of these enzymes can be inhibited by a wide range of chemically unrelated substances, such as phenothiazines and butyrophenones (Levin & Weiss, 1979; , naphthalene sulphonamides (Kobayashi et al., 1979) , Vinca alkaloids (Watanabe et al., 1979; , local anaesthetics (Volpi et al., 1981) . The most powerful inhibitor for calmodulin-mediated effects that has hitherto been described is calmidazolium, formerly referred to as compound R24571 (Gietzen et al., 1981; Van Belle, 1981) , which is a derivative of the antimycotic miconazole.
It has been demonstrated for several enzymes that unsaturated fatty acids, acidic phospholipids and limited tryptic digestion mimic the effect of calmodulin (Wolff & Brostrom, 1976; Depaoli-Roach et Taverna & Hanahan, 1980; Sarkadi et al., 1980; Niggli et al., 1981) . However, phosphatidylserine that was reported to be an effective activator of purified erythrocyte Ca2+-transport ATPase (Niggli et al., 1981) failed to exhibit a pronounced effect on brain phosphodiesterase (Wolff & Brostrom, 1976; Itano et al., 1981) .
In a comparative study we investigated the effect of several so-called calmodulin inhibitors on activation of brain phosphodiesterase and erythrocyte Ca2+-transport ATPase induced by calmodulin, oleic acid, phosphatidylserine and limited proteolysis.
Three structurally unrelated inhibitors were tested for their specificity: (1) trifluoperazine, a phenothiazine derivative; (2) penfiuridol, a butyrophenone analogue; and (3) calmidazolium, a complex imidazolium compound. The present study was designed to investigate further the mechanism of activation and inhibition of calmodulin-dependent enzymes.
Materials and methods
All reagents were of the highest purity available. Trifluoperazine dihydrochloride was a gift from Rohm Pharma (Darmstadt, Germany). Penfluridol and calmidazolium were obtained from Janssen Pharmaceutica (Beerse, Belgium). Oleic acid, phosphatidylserine (product no. P7769), 5'-nucleotidase, pepstatin A and soya-bean trypsin inhibitor were supplied by Sigma (Muinchen, Germany). Trypsin from bovine pancreas was a product of Boehringer (Mannheim, Germany) .
The lipophilic compounds penfluridol and calmidazolium were dissolved in dimethyl sulphoxide and added to the respective assay medium with vigorous mixing. The final concentration of dimethyl sulphoxide in the assay media including the controls was 0.5% (v/v) for Ca2+-transport ATPase and 1% (v/v) for phosphodiesterase.
Oleic acid and phosphatidylserine microdispersions were prepared by sonication (Branson Sonifier B12; approx. 2min at setting 2) of the substances in a buffer containing 0.1 mM-EGTA and 5mM-Mops (pH 7.0) under a stream of N2. Stock solutions of oleic acid and phosphatidylserine (3 mg/ml) were prepared fresh daily.
Preparation ofenzymes and calmodulin
Homogeneous calmodulin was prepared from bovine brain as described by Kakiuchi et al. (1981) . Membrane-bound human erythrocyte Ca2+-transport ATPase deficient in calmodulin was prepared by the method of . Calmodulin-sensitive phosphodiesterase was partially purified, based on the method of Wang & Desai (1977) . Briefly, phosphodiesterase was obtained from rat brain by homogenization in a buffer containing lOmM-Tris/HCl (pH 7.5) and 2 mm-EDTA followed by (NH4)2SO4 (55% saturated) precipitation of the 1000OOg supernatant. The redissolved pellet from the precipitation was applied to a DEAE-cellulose column (Whatman DE52) equilibrated with a buffer consisting of 20 mMTris/HC1 (pH 7.5), 1 mM-magnesium acetate, 1 mMimidazole, IOmM-16-mercaptoethanol, 0.1 mM-EGTA, and phosphodiesterase was eluted with the same buffer by a gradient of 50-350mM-NaCl. In addition all buffers needed for the preparation of phosphodiesterase contained 0.1 mM-di-isopropyl fluorophosphate and 0.05 ,ug of pepstatin A/ml. Tryptic digestion ofenzymes Ca2+-transport ATPase of disrupted erythrocyte membranes was digested at 37°C, usually by 0.2mg of trypsin/mg of erythrocyte membrane protein. Rat brain phosphodiesterase was digested at 370C by 30,ug of trypsin per mg of protein of the phosphodiesterase preparation. Proteolysis of both enzymes was performed in the respective assay medium. Usually, unless otherwise stated, digestion was terminated after 3 min by the addition of a 5-fold excess (w/w) of soya-bean trypsin inhibitor. Control experiments revealed that the presence of trypsin plus soya-bean trypsin inhibitor in the assay medium for all applied concentrations had no significant influence on the ATPase and phosphodiesterase activity.
Assay ofA TPase activity Ca2+-transport ATPase activity was monitored continuously for 8min at 370C by the phosphate released from ATP using the automated assay described by Arnold et al. (1976) . The assay medium contained, in a final incubation medium of 10ml, approx. 60ug of erythrocyte membrane protein/ml, 25 mM-Mops (pH 7.0), 100 mM-KCl, 0.2mM-ouabain, 1 mM-ATP, 2mM-MgCl2 and an Mg-Ca-EDTA buffer (0.2/0.2/0.4mM) to yield a free Ca2+ concentration of 36#M (Wolf, 1973 
Assay ofphosphodiesterase activity
Phosphodiesterase activity was determined at 370C as described by Wang & Desai (1977) based on the method of Butcher & Sutherland (1962) . This procedure involved coupling of the phosphodiesterase reaction with 5 '-nucleotidase reaction and measuring the P, produced within 30min. The assay mixture consisted of 40mM-Tris/HCI (pH 7.5), 40mM-imidazole, 3mM-magnesium acetate, 1.2mM-cyclic AMP and 0.1 mM-CaCl2 or 0.1 mM-EGTA.
Results
The effect of various activators on erythrocyte Ca2+-transport ATPase of disrupted membranes, deficient in calmodulin (the calmodulin content was determined to be approx. 20% of the value obtained for calmodulin-saturated membranes) is shown in Fig. 1 . Adding back calmodulin to the preparation results in fully activated Ca2+-transport ATPase at a calmodulin concentration >30 nM. Limited tryptic digestion. using 0.2-0.3 mg of trypsin/mg of erythrocyte membrane protein for 3 min at 370C, also gives maximum activation of the enzyme. In a narrow concentration range, being optimal at 30-60uM, oleic acid is a powerful activator of Ca2+-transport ATPase. Higher concentrations of oleic acid lead to a rapid decline in the ATPase activity. Phos- Fig. 3 (b) . In contrast with penfluridol and trifluoperazine, calmidazolium was found to be a more specific inhibitor of the calmodulin-induced activation of Ca2+-transport ATPase (Fig. 3c) .
Half-maximal inhibition of the activating effects of limited proteolysis or oleic acid on Ca2+-transport ATPase requires 7 and 25 times higher concentrations of the drug respectively, compared with the calmodulin-dependent fraction of the ATPase activity. As shown in Fig. 4 (a) trifluoperazine antagonizes activation of brain phosphodiesterase induced by calmodulin, oleic acid or phosphatidylserine with almost equal potency. However, in contrast with erythrocyte Ca2+-transport ATPase (Fig. 3a) , activation of phosphodiesterase by limited proteolysis is not inhibited by trifluoperazine in the investigated concentration range (<300pM). The same pattern of inhibition of activated phosphodiesterase is obtained with the butyrophenone derivative penfluridol (Fig. 4b) as with the phenothiazine compound trifluoperazine (Fig. 4a) . Evidently also penfluridol is unable to antagonize the activation of phosphodiesterase induced by mild tryptic digestion (Fig. 4b) .
Calmidazolium, the most potent inhibitor of calmodulin-mediated effects, is rather specific in antagonizing calmodulin-induced activation of phosphodiesterase (Fig. 4c) . Antagonism of the other activators of phosphodiesterase requires consider- ably higher concentrations of calmidazolium. In contrast with trifluoperazine and penfluridol, calmidazolium also antagonizes the activation of phosphodiesterase by tryptic digestion. Half-maximal inhibition of the stimulation produced by oleic acid, mild proteolysis or phosphatidylserine demands at least a 40-fold higher concentration of calmidazolium in comparison with the calmodulin-initiated activation of phosphodiesterase (Fig. 4c) . It is noteworthy that all inhibitors exhibit, at lower concentrations, as where they produce their inhibitory effects, some ability to amplify slightly the effect of some activators of phosphodiesterase (Figs. 4a-4c) . 
Discussion
Several acidic and hydrophobic compounds (Wolff & Brostrom, 1976; Al-Jobore & Roufogalis, 1981; Niggli et al., 1981) and limited proteolysis (Cheung, 1971; Depaoli-Roach et al., 1979; Taverna & Hanahan, 1980; Sarkadi et al., 1980; Klee, 1980; Niggli et al., 1981) were reported to mimic the regulatory effect of calmodulin on enzymes.
Activation of erythrocyte Ca2+-transport ATPase by oleic acid and mild tryptic digestion as reported by Niggli et al. (1981) for the purified enzyme and by Sarkadi et al. (1980) for erythrocyte inside-out vesicles was confirmed by our work on the ATPase of disrupted membranes (Fig. 1) . In contrast with previous reports (Al-Jobore & Roufogalis, 1981; Niggli et al., 1981), phosphatidylserine was ineffective as an activator of Ca2+-transport ATPase (Fig. 1) . This discrepancy might be due to different preparations and conditions applied in these studies. Purified ATPase (Niggli et al., 1981) both in the solubilized state and thus the incubation media contained a considerable amount of detergent, which might account for the activating effect of phosphatidylserine in their preparations. Stimulation of brain phosphodiesterase by mild proteolysis and oleic acid (Fig. 2) confirms the results from several laboratories (Cheung, 1971; Wolff & Brostrom, 1976; Klee, 1980) . A new finding is that phosphatidylserine at concentrations between 130 and 400pM (100-300ug/ml) also stimulates phosphodiesterase up to 82% of the activity of the maximally stimulated enzyme by calmodulin (Fig.   2 ). In contrast, Wolff & Brostrom (1976) obtained, even with 2mg of phosphatidylserine/ml, only a 25% increase over the basal phosphodiesterase activity and Itano et al. (1981) found no activating effect of phosphatidylserine at concentrations <300,ug/ml. The preparation of phosphatidylserine vesicles is of crucial importance (Gietzen et al., 1982b) . Only vesicles of the smallest possible size are capable of activating calmodulin-deficient phosphodiesterase. This is in agreement with the finding of Itano et al. (1981) , who showed a stimulation of phosphodiesterase by phosphatidylserine when adding small amounts of Triton X-100, which results in the formation of smaller particles of phosphatidylserine.
'Calmodulin inhibitors', such as trifluoperazine and penfluridol, can antagonize the effects of all types of activators (calmodulin, oleic acid, limited proteolysis) on erythrocyte Ca2+-transport ATPase in a similar fashion and concentration range (Figs. 3a  and 3b ). In addition, both drugs exhibit an equal potency to inhibit activation of brain phosphodiesterase by oleic acid, phosphatidylserine or calmodulin (Figs. 4a and 4b) . However, in contrast with Ca2+-transport ATPase, trifluoperazine and penfluridol failed to inhibit activation of phosphodiesterase by limited tryptic digestion (Figs. 4a  and 4b ). From these results the following conclusions can be drawn. (1) Penfluridol and trifluoperazine bind, in addition to calmodulin, also to erythrocyte Ca2+-transport ATPase, since activation by both tryptic digestion and calmodulin can be completely antagonized in a similar concentration range. Inhibition of trypsin-activated Ca2+-transport ATPase due to perturbation of the lipid environment of the enzyme is improbable, since in a previous report it was shown that inhibition of the basal (in the absence of calmodulin) Ca2+-transport ATPase activity requires at least 10 times higher concentrations of the drugs compared with the calmodulin-or trypsin-stimulated fraction of the ATPase activity. However, our experiments do not allow us to ascertain whether the binding site on the ATPase is made accessible by trypsin digestion or alternatively whether it is already accessible in the native enzyme. In a recent report we demonstrated that vinblastine, another inhibitor of calmodulin-mediated effects, has a binding site on native Ca2+-transport ATPase (Gietzen et al., 1982a) . So it may be that the binding site for penflurdiol and trifluoperazine on Ca2+_ transport ATPase is already accessible in the native enzyme. (2) Brain phosphodiesterase obviously has no binding site for these drugs, since it was reported that native phosphodiesterase does not bind antipsychotic drugs (Weiss & Sellinger-Barnette, 1981) and our results indicate that trypsin-treated phosphodiesterase cannot be inhibited by penfluridol and trifluoperazine. (3) Antagonism by these drugs of the activators (calmodulin, oleic acid and phosphatidylserine) of Ca2+-transport ATPase and phosphodiesterase, occurring in the same concentration range, implies a general mode of activation and inhibition of these enzymes.
Calmidazolium, the most potent inhibitor of calmodulin-regulated functions (Gietzen et al., 1981; Van Belle, 1981) , was found to be a more specific inhibitor of calmodulin-induced activation of both enzymes since antagonism of the other activators required much higher concentrations of the drug. In addition, calmidazolium inhibits proteolysis-induced activation of phosphodiesterase, which cannot be reversed by penfluridol and trifluoperazine. The specificity of calmidazolium antagonism of calmodulin stimulation is more pronounced in the phosphodiesterase system, compared with the Ca2+-transport ATPase. The discrepancy could be due to the distribution of the lipophilic compound in the lipid bilayer of the erythrocyte membranes, so that the concentration, at the target in this system is unknown and less than expected. So it cannot be excluded that the same differences in affinity, as determined for the phosphodiesterase system, may exist also in the Ca2+-transport ATPase system. Inhibition even of the proteolysis-induced activation of phosphodiesterase by calmidazolium may be due to its high potency.
On the basis of the results from several laboratories, including ours, we have developed a hypothetical model (Fig. 5) by which all types of activation and inhibition phenomena of calmodulin-regulated enzymes can be described simply by the assumption of hydrophobic and ionic interactions. (1) Calmodulin has two important structural features: acidity (Cheung, 1980) and hydrophobicity, of which the latter was shown to be induced by binding of Ca2+ (LaPorte et al., 1980) . Generally calmodulin can be considered to be an anionic amphiphile. Most substances that can mimic the activity of calmodulin, such as phosphatidylserine or oleic acid (Wolff & Brostrom, 1976; Niggli et al., 1981; Al-Jobore & Roufogalis, 1981) The scheme describes our hypothesis for the mechanism by which calmodulin-dependent enzymes may be activated and by which the induced activation may be antagonized. The phenomena simply are described on the basis of hydrophobic and ionic interactions. Activators (calmodulin, oleic acid or phosphatidylserine) are depicted as anionic amphiphiles, whereas so-called calmodulin inhibitors are depicted as cationic amphiphiles. The hatched areas symbolize hydrophobic regions. An inhibitory peptide sequence of the calmodulin-regulated enzymes, being positively charged and having a hydrophobic site, is assumed. The inhibitory effect of this polypeptide is suppressed by interaction with anionic activators leading to its displacement or by cleavage with trypsin. The activated enzyme may be inhibited by complexation of the activator by the inhibitor and for some enzymes in addition by direct interaction of the inhibitor with the calmodulin-dependent enzyme. Abbreviation used: AC, active centre. Only a section of the calmodulin-dependent enzyme is shown.
and possess in addition a hydrophobic region (Vincenzi, 1981) . They can be considered as cationic amphiphiles. Most 'calmodulin inhibitors' were shown to bind to calmodulin in a Ca2+-dependent manner (Levin & Weiss, 1979) . Therefore binding probably occurs because of the above noted complementary structural features via ionic and hydrophobic interactions. Weiss et al. (1980) have shown the importance of the opposite charges in calmodulin and the inhibitors. A complex was only formed when the pH was above the isoelectric point of calmodulin and below the PKa of the inhibitor. (3) Limited proteolysis of calmodulin-regulated enzymes mimics the activation induced by calmodulin and by this action simultaneously calmodulin sensitivity is eliminated. It was suggested that these enzymes possess a peptide sequence whose inhibitory action on the enzymes is suppressed by binding of calmodulin as well as by its cleavage through trypsin (Klee, 1980; Sarkadi et al., 1980) . The calmodulin receptor of these enzymes is thought to be located on the inhibitory peptide sequence. When phosphodiesterase was treated with trypsin in the presence of calmodulin it was shown that cleavage of the inhibitory protein proceeds faster, which is compatible with the explanation that the enzyme unfolds on binding of calmodulin (Klee, 1980 Ca2+-dependently bound. Such a dual role of calmodulin was shown to be relevant for phosphorylase kinase (Cohen et al., 1978) . The fact that calmidazolium displays a higher specificity for calmodulin-induced activation compared with the other types of stimulation may be due to its bulky structure. Complexation of this compound by oleic acid or phosphatidylserine demands its incorporation into the micellar or vesicular structure, which might be more difficult than simple attachment of the drug to calmodulin. Also the low affinity of calmidazolium for the trypsin-treated ATPase may be due to a steric problem.
We are aware that part of our proposed mechanism describing the activation of calmodulin-regulated enzymes and the inhibition of the induced activation is speculative, but it may serve as a useful working hypothesis for further experimental work.
